Literature DB >> 22447316

The tumor microenvironment in hepatocellular carcinoma (review).

Giulia Costanza Leonardi1, Saverio Candido, Melchiorre Cervello, Daria Nicolosi, Fabio Raiti, Salvatore Travali, Demetrios A Spandidos, Massimo Libra.   

Abstract

The tumor microenvironment has been largely studied as a dynamic system orchestrated by inflammatory cells, including cancer cells, stroma as well as the extracellular matrix. It is useful to describe and predict the phenotypic characteristics of cancer. Furthermore, a better understanding of its interplay with the various aspects of the tumor cells may be utilized for the discovery of novel molecular targets. Liver cancer is considered a model of the relation occurring between the tumor micro-environment and tumor development. The chronic inflammatory status of the liver, sustained by the infection of hepatitis viruses, as well as the production of cytokines and growth factors within the parenchyma, lead to an intricate microenvironment. The identification of novel molecular therapeutic targets may improve the outcome of patients with liver cancer as it remains the third leading cause of cancer death worldwide. In the present study, the tumor microenvironment in hepatocellular carcinoma (HCC) was explored by a review of the literature. Studies on hepatitis virus infections and the consequent chronic inflammatory status were examined. In this context, immune-mediated and/or virus-related molecular mechanisms have been hypothesized as being responsible for liver cancer development. The interlink among HCC microenvironment components, comprising cellular elements, cytokines, growth factors and several proteins is also described together with the role of matrix metalloproteinases in HCC development. Finally, the rationale for targeting tumor-stromal interface is summarized in the context of new therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22447316     DOI: 10.3892/ijo.2012.1408

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  93 in total

1.  Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade.

Authors:  Hongchi Yu; Yang Shen; Jingsi Jin; Yingying Zhang; Tang Feng; Xiaoheng Liu
Journal:  Cell Adh Migr       Date:  2017-06-22       Impact factor: 3.405

2.  Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.

Authors:  Petr Pancoska; Brian I Carr; Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Gian Ludovico Rapaccini; Maria Di Marco; Luisa Benvegnù; Marco Zoli; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Franco Trevisani
Journal:  Semin Oncol       Date:  2014-04-24       Impact factor: 4.929

3.  miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.

Authors:  Xiaoxia Sun; Jian Zhang; Zhaohua Hou; Qiuju Han; Cai Zhang; Zhigang Tian
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver.

Authors:  Tung-Ching Ho; Er-Yea Wang; Kun-Huei Yeh; Yung-Ming Jeng; Jau-Hau Horng; Li-Ling Wu; Yi-Tzu Chen; Hsuan-Cheng Huang; Chia-Lang Hsu; Pei-Jer Chen; Shiou-Hwei Yeh; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-05       Impact factor: 11.205

Review 5.  Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice.

Authors:  Kornelius Schulze; Jessica Zucman-Rossi
Journal:  Hepat Oncol       Date:  2015-07-27

6.  Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms.

Authors:  Bani Mukhopadhyay; Kornel Schuebel; Partha Mukhopadhyay; Resat Cinar; Grzegorz Godlewski; Keming Xiong; Ken Mackie; Martin Lizak; Qiaoping Yuan; David Goldman; George Kunos
Journal:  Hepatology       Date:  2015-02-17       Impact factor: 17.425

Review 7.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Pre-diagnostic urinary 15-F2t -isoprostane level and liver cancer risk: Results from the Shanghai Women's and Men's Health Studies.

Authors:  Xiao Ma; Yu-Ting Tan; Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Qing Lan; Nathaniel Rothman; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

Review 9.  Potential role of High mobility group box 1 in hepatocellular carcinoma.

Authors:  Rong-Rong Zhou; Xu-Yuan Kuang; Yan Huang; Ning Li; Ming-Xiang Zou; Dao-Lin Tang; Xue-Gong Fan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 10.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.